Combining Targeted Agents for the Treatment of Lung Cancer

Heather Wakelee, MD, associate professor, Stanford University School of Medicine, discusses the need to combine agents for the treatment of lung cancer.

Clinical Pearls

Heather Wakelee, MD, associate professor, Stanford University School of Medicine, discusses the need to combine agents for the treatment of lung cancer.

  • It is widely believed that 1 molecularly-targeted agent will not be able to cure lung cancer.
  • Long term responses have been observed with 1 targeted agent.
  • Research needs to be conducted regarding which combinations of agents will be most beneficial or curative.